Pfizer announced it is expanding its generics portfolio through innovative licensing deals, increasing access to medicines for billions worldwide. The company says it has entered into licensing agreements with two pharmaceutical companies based in India.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
